KR0178543B1 - N,n'-이치환된 구아니딘과 흥분유발 아미노산 길항제로서 그 사용방법 - Google Patents

N,n'-이치환된 구아니딘과 흥분유발 아미노산 길항제로서 그 사용방법 Download PDF

Info

Publication number
KR0178543B1
KR0178543B1 KR1019920702121A KR920702121A KR0178543B1 KR 0178543 B1 KR0178543 B1 KR 0178543B1 KR 1019920702121 A KR1019920702121 A KR 1019920702121A KR 920702121 A KR920702121 A KR 920702121A KR 0178543 B1 KR0178543 B1 KR 0178543B1
Authority
KR
South Korea
Prior art keywords
guanidine
isopropylphenyl
ethylphenyl
naphthyl
iodinephenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019920702121A
Other languages
English (en)
Korean (ko)
Inventor
에카드 웨버
존 에프. 더블유. 키이나
Original Assignee
멜린다 더불유. 그리어
스테이트 오브 오리건 액팅 바이 앤드 쓰루 더 오리건 스테이트 보오드 오브 하이어 에쥬케이숀 액팅 포 앤드 온 비핼프 오브 더 오리건 헬쓰 사이언스 유니버시티 포트랜드 오리건 앤드 더 유니버시티 오브 오리건 유젠 오리건
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 멜린다 더불유. 그리어, 스테이트 오브 오리건 액팅 바이 앤드 쓰루 더 오리건 스테이트 보오드 오브 하이어 에쥬케이숀 액팅 포 앤드 온 비핼프 오브 더 오리건 헬쓰 사이언스 유니버시티 포트랜드 오리건 앤드 더 유니버시티 오브 오리건 유젠 오리건 filed Critical 멜린다 더불유. 그리어
Application granted granted Critical
Publication of KR0178543B1 publication Critical patent/KR0178543B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019920702121A 1990-03-02 1991-03-04 N,n'-이치환된 구아니딘과 흥분유발 아미노산 길항제로서 그 사용방법 Expired - Fee Related KR0178543B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US487,033 1990-03-02
US07/487,033 US5093525A (en) 1986-07-10 1990-03-02 N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
PCT/US1991/001448 WO1991013056A1 (en) 1990-03-02 1991-03-04 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists

Publications (1)

Publication Number Publication Date
KR0178543B1 true KR0178543B1 (ko) 1999-05-15

Family

ID=23934135

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920702121A Expired - Fee Related KR0178543B1 (ko) 1990-03-02 1991-03-04 N,n'-이치환된 구아니딘과 흥분유발 아미노산 길항제로서 그 사용방법

Country Status (7)

Country Link
US (1) US5093525A (enExample)
EP (1) EP0516748A1 (enExample)
JP (1) JPH05509077A (enExample)
KR (1) KR0178543B1 (enExample)
AU (1) AU652555B2 (enExample)
CA (1) CA2077258A1 (enExample)
WO (1) WO1991013056A1 (enExample)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190976A (en) * 1986-07-10 1993-03-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And University Of Oregon N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
DE69133065T2 (de) * 1990-03-02 2003-02-27 The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon Health Sciences University, Portland Tri- und tetra-substituierte guanidine und deren verwendung als antagonisten von exzitatorischen aminosäuren
WO1991018868A1 (en) * 1990-05-25 1991-12-12 STATE OF OREGON, acting by and through the OREGON STATE BOARD OF HIGHER EDUCATION, acting for and onbehalf of the OREGON HEALTH SCIENCES UNIVERSITY Substituted guanidines having high binding to the sigma receptor and the use thereof
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
DE69233479T2 (de) * 1991-02-08 2006-03-16 Scion Pharmaceuticals, Inc., Medford Substituierte Guanidine und Derivate hiervon als Modulatoren der Freisetzung von Neurotransmittern und neue Methode zur Identifizierung von Inhibitoren der Neurotransmitter-Freisetzung
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
DK68592D0 (da) * 1992-05-25 1992-05-25 Novo Nordisk As Celle
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
ES2204920T3 (es) * 1993-05-27 2004-05-01 Cenes Limited Guanidinas substituidas terapeuticas.
AU705487B2 (en) * 1993-11-23 1999-05-20 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
WO1995020950A1 (en) 1994-02-03 1995-08-10 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US6011021A (en) * 1996-06-17 2000-01-04 Guilford Pharmaceuticals Inc. Methods of cancer treatment using naaladase inhibitors
US5935606A (en) * 1995-07-31 1999-08-10 Sagen; Jaqueline Reversing excitotoxic CNS damage by cellular implantation
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
DE19621038A1 (de) * 1996-05-24 1997-11-27 Boehringer Ingelheim Kg Aminoguanidine, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
US5795877A (en) * 1996-12-31 1998-08-18 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US6071965A (en) * 1996-06-17 2000-06-06 Guilford Pharmaceuticals Inc. Phosphinic alkanoic acid derivatives
US5863536A (en) * 1996-12-31 1999-01-26 Guilford Pharmaceuticals Inc. Phosphoramidate derivatives
US5902817A (en) * 1997-04-09 1999-05-11 Guilford Pharmaceuticals Inc. Certain sulfoxide and sulfone derivatives
US5672592A (en) * 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
US6025344A (en) 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Certain dioic acid derivatives useful as NAALADase inhibitors
US6384022B1 (en) 1996-06-17 2002-05-07 Guilford Pharmaceuticals Inc. Prodrugs of NAALAdase inhibitors
US6046180A (en) * 1996-06-17 2000-04-04 Guilford Pharmaceuticals Inc. NAALADase inhibitors
US6054444A (en) 1997-04-24 2000-04-25 Guilford Pharmaceuticals Inc. Phosphonic acid derivatives
US6025345A (en) * 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
TR199802638T2 (xx) 1996-06-17 1999-03-22 Guilford Pharmaceuticals, Inc. Kanser tedavisinde naaladase inhibit�rleri kullan�m�.
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) * 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US5962521A (en) * 1997-04-04 1999-10-05 Guilford Pharmaceuticals Inc. Hydroxamic acid derivatives
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
US6063819A (en) * 1997-02-21 2000-05-16 Cypros Pharmaceutical Corp. Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels
WO1998041223A1 (en) * 1997-03-20 1998-09-24 The Regents Of The University Of California N-methyl-d-aspartate receptor channel blockers and method for identifying such
US5981209A (en) * 1997-12-04 1999-11-09 Guilford Pharmaceuticals Inc. Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
US6028216A (en) * 1997-12-31 2000-02-22 Guilford Pharmaceuticals Inc. Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives
US6121252A (en) * 1998-03-30 2000-09-19 Guilford Pharmaceuticals Inc. Phosphinic acid derivatives
US6395718B1 (en) 1998-07-06 2002-05-28 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
US6265609B1 (en) 1998-07-06 2001-07-24 Guilford Pharmaceuticals Inc. Thio-substituted pentanedioic acid derivatives
TR200100025T2 (tr) 1998-07-06 2001-12-21 Guilford Pharmaceuticals Inc. Farmasötik bileşikler ve kompozisyonlar olarak faydalı naaladaz inhibitörleri.
US6444657B1 (en) 1998-12-31 2002-09-03 Guilford Pharmaceuticals Inc. Methods for treating certain diseases using naaladase inhibitors
WO2000072800A2 (en) * 1999-05-28 2000-12-07 Smithkline Beecham Corporation Il-8 receptor antagonists
US6875759B1 (en) 1999-07-21 2005-04-05 Kadmus Pharmaceuticals Substituted guanidines and the use thereof
US6313159B1 (en) 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
WO2002072542A2 (en) * 2001-03-08 2002-09-19 Emory University Ph-dependent nmda receptor antagonists
CA2477604A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CN103058957A (zh) 2007-06-29 2013-04-24 埃莫里大学 用于神经保护的nmda受体拮抗剂
CN102014897B (zh) 2008-04-21 2015-08-05 西格纳姆生物科学公司 化合物、组合物和其制备方法
WO2010048164A2 (en) * 2008-10-20 2010-04-29 University Of South Florida N,n'-di-p-bromophenyl guanidine treatment for stroke at delayed timepoints
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
BR112014008589B1 (pt) * 2011-10-11 2022-06-14 Universidad Nacional De Quilmes Compostos derivados de fenil-guanidina, processo para a preparação destes, uso dos mesmos e composição farmacêutica

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1677235A (en) * 1928-07-17 Balph v
US1422506A (en) * 1921-07-02 1922-07-11 Dovan Chemical Corp Process of making diphenylguanidine
US1642180A (en) * 1922-11-27 1927-09-13 Du Pont Di-para-xylylguanidine
US1597233A (en) * 1923-02-27 1926-08-24 Albert C Burrage Vulcanization of rubber
US1672431A (en) * 1925-11-30 1928-06-05 Firm Chem Fab Auf Actien Vorma Symmetrical diarylized guanidine compounds
US2362915A (en) * 1940-12-24 1944-11-14 Courtaulds Ltd Process for improving the fastness to washing of dyed cellulosic textile materials
US2633474A (en) * 1951-07-21 1953-03-31 Monsanto Chemicals 1, 3-bis (o-ethylphenyl) guanidine
US3320229A (en) * 1963-08-26 1967-05-16 Stauffer Chemical Co Complexes of guanidines with completely halogenated acetones
US3479437A (en) * 1963-08-26 1969-11-18 Stauffer Chemical Co Guanidine complexes as fungicides
US3976643A (en) * 1973-07-13 1976-08-24 William H. Rorer, Inc. Guanidines
DE2609534A1 (de) * 1975-03-10 1976-09-30 Ciba Geigy Ag N,n'-diphenyl-guanidin-derivate
US4663263A (en) * 1984-10-19 1987-05-05 Canon Kabushiki Kaisha Toner, charge-imparting material and composition containing substituted guanidine compound for electrophotography
US4709094A (en) * 1986-07-10 1987-11-24 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Sigma brain receptor ligands and their use
US4906779A (en) * 1986-07-10 1990-03-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Also Published As

Publication number Publication date
EP0516748A1 (en) 1992-12-09
WO1991013056A1 (en) 1991-09-05
EP0516748A4 (enExample) 1994-04-13
US5093525A (en) 1992-03-03
CA2077258A1 (en) 1991-09-03
AU652555B2 (en) 1994-09-01
AU7484591A (en) 1991-09-18
JPH05509077A (ja) 1993-12-16

Similar Documents

Publication Publication Date Title
AU652555B2 (en) N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
US5190976A (en) N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
US4906779A (en) N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
US5336689A (en) Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5262568A (en) Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
KR100353486B1 (ko) 삼치환및사치환된구아니딘류및이를함유하는약제조성물
DE69432984T2 (de) Therapeutische substituierte guanidine
JP2007161725A (ja) 治療用グアニジン類
US20030055009A1 (en) Non-peptidic cyclophilin binding compounds and their use
US20080032981A1 (en) Aryl n-cyanoguanidines and methods related thereto
US6251898B1 (en) Medical use of fluorenone derivatives for treating and preventing brain and spinal injury
JP3230678B2 (ja) Ｎ，ｎ’―ジ置換グアニジンおよび興奮性アミノ酸アンタゴニストとしてのそれらの用途
US3870796A (en) Pharmaceutical preparation
JP2002012543A (ja) Ｎ，ｎ’−ジ置換グアニジンおよび興奮性アミノ酸アンタゴニストとしてのそれらの用途

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

St.27 status event code: A-5-5-P10-P19-oth-PG1701

Patent document republication publication date: 20000315

Republication note text: Request for Correction Notice

Gazette number: 1001785430000

Gazette reference publication date: 19990515

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20021125

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20031125

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20031125